The objective behind this provocative meeting is to bring together all those concerned about drug discovery (academia, industry, biotech, funders, charities and patient groups) to honestly and openly debate the bottlenecks that are hindering innovation and the tangible results, as perceived by these communities.
The conference will consist of six panels discussing different scientific and strategic challenges, each composed by three panellists and two chairs. Individual talks by the panellists will be followed by critical and direct questioning by the chairs, who will encourage audience participation.
Our vision is to establish practical opportunities for different stakeholders – traditional and new – to map and create better, more efficient approaches for this quickly-evolving ecosystem.
Please find more information from below link: